General

First published

Therabody bought Embr’s IP. Who handles an existing Wave 2?

Our interpretation

If you already own a Wave 2, keep contacting Embr Labs for orders and product support. Therabody announced that it acquired Embr’s intellectual property portfolio, not that it took over every customer obligation. The wristband predates the deal. If you are considering a purchase, check the seller, support contact and written warranty for that specific offer. The announcement does not set a launch date for a new Therabody product or establish a change in warranty terms.

The Signal in brief

What changed

Therabody announced on 18 November at 09:00 US Eastern time (22:00 Singapore time) that it had acquired Embr Labs’ intellectual property portfolio. The buyer explicitly directed Wave 2 owners to keep contacting Embr for orders and product support. This dates the announcement, not the signing or the transfer of any individual warranty.

Why it matters

The name on a technology deal is not necessarily the name on your receipt. If your existing band has an order or product issue, going straight to the support team named by the buyer can avoid a wasted enquiry. It does not guarantee the answer will be a replacement or refund.

Who it affects

Existing Wave 2 owners, people considering a purchase and retailers fielding questions about the transaction. The buyer’s direction expressly names Wave 2, not every previous model.

Where

United States announcement; check exact seller, model, contract and country.

What to watch

Check current Embr instructions when opening a case. Watch separately for a written change in support arrangements, a model-specific warranty notice or an orderable Therabody product listing. Each answers a different question.

What changed for the owner?
  • Who acquired the IP portfolio?Therabody, per its announcement
  • Who handles Wave 2 support enquiries?Continue to contact Embr Labs
  • Did a particular warranty transfer?No transfer document reviewed
  • Can I buy a newly announced device?The buyer did not announce a dated new product listing
Support contact is not a legal warranty determination.
Sources

Purchase price, detailed transfer documents, a future model or launch date, and changes to particular sellers’ obligations are not established. No clinical or performance judgment is made.

Explore this signal

Emerging data

A customer who bought Wave 2 from a shop and another who obtained one by subscription may both wear the same device. Their paperwork can tell different stories. Embr announced retail distribution partnerships in 2023 and a subscription offer in 2024. Those are reasons to check the original arrangement, not proof the old offers are still open. If Therabody develops this portfolio into a new device, the first useful buying signal will be a dated, orderable listing with a named seller, market and written support terms. The acquisition alone does not establish any of those.

Report this passage

The connection

IP can give a buyer rights to develop technology without moving every customer relationship. MIT documented the original wristband in 2017; Embr announced Wave 2 in 2021. Neither product began with this deal. In May 2026 Embr also announced public developer tools for Wave 2. That identifies a pre-existing software element, not a promise of future app support.

The wristband predates the acquisition
  1. 2017-09-27MIT reports on original wristband
  2. 2021-04-14Embr announces Wave 2
  3. 2026-11-18Therabody announces IP acquisition, not a new device
These are publication dates, not necessarily execution or first-sale dates.
Sources

Report this passage

The opportunity

For an existing Wave 2, find your original order confirmation and contact Embr Labs through its official support form. Keep the model, seller, order reference and applicable written terms. If buying now, identify the seller and country and read the terms for that offer before paying. For a gift, reseller order, subscription or first-generation band, ask about that exact arrangement.

If support asks which item you have, the 2021 manual identifies E100 and E101 as Wave 2 device models; E151 and E152 refer to chargers. Quote the label on the affected item. An old manual is not proof that its warranty period applies to your purchase now.

Where to start with the paperwork
  1. 1Shopping now? Check exact offer, model, territory and written terms
  2. 2Already own Wave 2? Identify the seller on your receipt and contact Embr Labs
  3. 3Different generation or subscription? Ask about that arrangement
  4. 4New official instructions? Follow them for the model and market they cover
Separate reader routes, not a promise of coverage or reimbursement.

What could happen next

  1. First-order consequence

    Existing Wave 2 customers have a named first contact. The buyer does not say they should move their order enquiry to Therabody.

  2. Second-order consequence

    A seller may receive questions about which terms still apply. A support team can route an enquiry without being the party legally responsible for every claim.

  3. Third-order consequence

    If a new product appears, retailers could compare its written support terms with those of existing Wave 2 offers. No such launch is established here.

  4. Fourth-order consequence

    A separately documented distribution or support agreement could change the route in a named country. Do not transfer that conclusion to other sellers or territories.

  5. Fifth-order consequence

    Only actual listings and subsequent orders could start to show commercial use of the acquired portfolio. Even then, availability would not prove broad sales or medical benefit.

Costs, benefits and assumptions

There is no disclosed price for the portfolio in the buyer release, no verified new-device price and no basis to calculate a payback period. For an owner, the immediate decision is whether another purchase is necessary at all. Check the existing order and support response before treating a replacement as an unavoidable expense.

What would change our view?

The buyer can hold or develop the IP without launching a retail product. A future official support notice could change the contact route. Silence about a warranty assignment does not prove an assignment occurred or did not occur.

Alternative explanation

A retailer, subscription provider or local distributor may hold the relevant order record. Ask the identified seller for written terms while using Embr’s named product-support route; do not assume these are the same role.

What would confirm it

For a changed support route, require current official instructions naming the model and market. For a new product, look for a dated orderable listing naming the model, seller and territory. For a particular warranty claim, seek the applicable terms and a case-specific response.

What would disprove it

A later official direction naming a different contact would supersede the current routing advice within its stated scope. A concept image, developer toolkit or strategic statement is not a product available to buy.

Evidence and sources

  • Therabody, 18 Nov 2026

    Publisher: Therabody via PR Newswire

    Original language: English

    published date precision: day

    retrieved date precision: day

    Source publication date 2026-11-18

    Source retrieval date 2026-11-19

    Coverage and independence

    buyer’s IP acquisition announcement and Wave 2 order/support direction. Not executed instrument.

    View source
  • Embr Labs, 14 Apr 2021

    Publisher: Embr Labs via PR Newswire

    Original language: English

    published date precision: day

    retrieved date precision: day

    Source publication date 2021-04-14

    Source retrieval date 2026-11-19

    Coverage and independence

    original Wave 2 announcement, not a 2026 launch.

    View source
  • MIT News, 27 Sep 2017

    Publisher: MIT News

    Original language: English

    published date precision: day

    retrieved date precision: day

    Source publication date 2017-09-27

    Source retrieval date 2026-11-19

    Coverage and independence

    historical original wristband and founders, no verification of 2026 deal.

    View source
  • Embr support contact

    Publisher: Embr Labs

    Original language: English

    retrieved date precision: day

    Source retrieval date 2026-11-19

    Coverage and independence

    direct route to message the team. No guarantee of individual resolution.

    View source
  • Embr registration

    Publisher: Embr Labs

    Original language: English

    retrieved date precision: day

    Source retrieval date 2026-11-19

    Coverage and independence

    direct order confirmation serves as registration; retailer purchases and gifts are directed to register. Registration helps check eligibility, not automatic coverage.

    View source
  • Embr international shopping

    Publisher: Embr Labs

    Original language: English

    retrieved date precision: day

    Source retrieval date 2026-11-19

    Coverage and independence

    retail channels can differ by location. No guarantee that a named retailer has stock or honours a particular claim.

    View source
  • Embr warranty FAQ

    Publisher: Embr Labs

    Original language: English

    retrieved date precision: day

    Source retrieval date 2026-11-19

    Coverage and independence

    describes a limited warranty and points readers to Terms of Sale; verify the applicable written terms with the seller.

    View source
  • Embr Labs distribution announcement, 5 Jan 2023

    Publisher: Embr Labs via PR Newswire

    Original language: English

    published date precision: day

    retrieved date precision: day

    Source publication date 2023-01-05

    Source retrieval date 2026-11-19

    Coverage and independence

    historical retailer routes illustrate why a buyer should identify the original seller. Not proof of inventory, an active distribution contract or warranty terms today.

    View source
  • Embr Labs subscription announcement, 2 Apr 2024

    Publisher: Embr Labs via PR Newswire

    Original language: English

    published date precision: day

    retrieved date precision: day

    Source publication date 2024-04-02

    Source retrieval date 2026-11-19

    Coverage and independence

    Embr launched a subscription then, so purchase and subscription paperwork may differ. Historical pricing and terms do not establish current offers or individually applicable rights.

    View source
  • Embr Terms of Service, v2.7

    Publisher: Embr Labs

    Original language: English

    retrieved date precision: day

    Source retrieval date 2026-11-19

    Coverage and independence

    explicitly marked updated 2 Jul 2026, not first published that day. This is a dated version of terms, not evidence the 2026 acquisition transferred any particular retail warranty.

    View source
  • Therabody’s own initiative launch video, 28 Jan 2025

    Publisher: Therabody

    Original language: English

    published date precision: day

    retrieved date precision: day

    Source publication date 2025-01-28

    Source retrieval date 2026-11-19

    Coverage and independence

    its stated priorities already included menopause. This establishes prior buyer strategy, not an Embr product launch, clinical result, consumer demand or change to support.

    View source
  • Wave 2 developer tools announcement

    Publisher: Embr Labs via PR Newswire

    Original language: English

    published date precision: day

    retrieved date precision: day

    Source publication date 2026-05-07

    Source retrieval date 2026-11-19

    Coverage and independence

    07:00 US Eastern time. Embr announced developer tools for the existing Wave 2. No conclusion about clinical outcomes, future software maintenance or warranty coverage.

    View source
  • Embr Wave 2 manual, public filing exhibit 5247966

    Publisher: Embr Labs; public FCC filing exhibit via FCCID.io

    Original language: English

    published date precision: day

    retrieved date precision: day

    Source publication date 2021-05-15

    Source retrieval date 2026-11-19

    Coverage and independence

    Public-record availability date: 15 May 2021; file created 13 April and submitted 14 May. The manual distinguishes device and charger model IDs. Its historical warranty wording does not settle a current claim.

    View source

Gaps in the evidence

Therabody is the source for its acquisition announcement. Historical Embr releases establish prior devices and sales channels, not current stock or contractual succession. MIT covers the original wristband, not the transaction. No transfer instrument or individual warranty determination was reviewed.

Explore the research

Research layers

Research entries

  1. Layer name

    01 Money Flow

    Research and limitations

    portfolio acquisition announced; consideration and settlement not established.

  2. Layer name

    02 Early Orders / Deposits

    Research and limitations

    no post-deal retailer order or deposit established.

  3. Layer name

    03 Bottlenecks

    Research and limitations

    converting IP into a saleable product is separate from buying it; no measured delay.

  4. Layer name

    04 Second / Third-Tier Beneficiaries

    Research and limitations

    existing owners have an identified support route; paid supplier gains unestablished.

  5. Layer name

    05 Listed Company Finances And Quote

    Research and limitations

    no verified transaction valuation, margin or quoted pure-play exposure.

  6. Layer name

    06 Transparent Customer Unit Economics

    Research and limitations

    no production cost, price, sell-through or payback evidence.

  7. Layer name

    07 Insider And Institutional Activity

    Research and limitations

    not assessed; no inference.

  8. Layer name

    08 Hiring

    Research and limitations

    no deal-specific hiring established.

  9. Layer name

    09 Public Procurement And Budgets

    Research and limitations

    not applicable to the disclosed private IP transaction.

  10. Layer name

    10 Foreign-Language Warning

    Research and limitations

    cited evidence is English; no multilingual corroboration claimed.

  11. Layer name

    11 Behaviour And Payment

    Research and limitations

    support direction documented, not customer satisfaction or purchase activity.

  12. Layer name

    12 Contradictory Market Readings

    Research and limitations

    the buyer can develop or hold IP without launching a new product.

  13. Layer name

    13 Observed Missing Expected Activity

    Research and limitations

    no dated launch or detailed warranty transfer in the cited announcement.

  14. Layer name

    14 Commercial Pilots And Approvals

    Research and limitations

    no claim of clinical efficacy, authorisation or approval of a future product.

  15. Layer name

    15 Competitive Weaknesses

    Research and limitations

    no market-share shift or displacement demonstrated.

  16. Layer name

    16 Cross-Border Spillovers

    Research and limitations

    do not generalise warranty or consumer rights across jurisdictions.

  17. Layer name

    17 Dated Prior Otr Outcomes / Failures

    Research and limitations

    no earlier matched outcome established; not a forecast hit.

  18. Layer name

    18 Investor Awareness / Priced-In Test

    Research and limitations

    no verified market-pricing or investor-awareness conclusion.

  19. Layer name

    19 Strongest Disconfirming Facts

    Research and limitations

    new official support instructions supersede today’s advice; a dated orderable listing establishes observed availability only for that model, seller, territory and observation date, not efficacy or past sales.

  20. Layer name

    20 Action Clock / First Proof / Money / Stop Rule

    Research and limitations

    check current support instructions when opening a case; recheck at any new published warranty, named product or order disclosure. Stop short of paying on the basis of the acquisition headline.

Back to Signals

AI powered research